Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000727078 | SCV000705444 | uncertain significance | not provided | 2017-02-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000727078 | SCV000727274 | likely benign | not provided | 2020-06-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001088498 | SCV001006384 | likely benign | Alstrom syndrome | 2024-12-31 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000592923 | SCV001339090 | likely benign | not specified | 2020-03-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002456303 | SCV002614423 | likely benign | Cardiovascular phenotype | 2019-06-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001088498 | SCV002080482 | likely benign | Alstrom syndrome | 2021-01-06 | no assertion criteria provided | clinical testing |